Vivani Medical
VANI
30 hedge funds and large institutions have $27.3M invested in Vivani Medical in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 6 closing their positions.
2,026% more capital invested
Capital invested by funds: $1.28M → $27.3M (+$26M)
473% more call options, than puts
Call options by funds: $212K | Put options by funds: $37K
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
36% more funds holding
Funds holding: 22 → 30 (+8)
3.82% more ownership
Funds ownership: 0.99% → 4.81% (+3.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$4.98M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.59M |
| 3 |
BlackRock
New York
|
+$1.69M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.04M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$871K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$177K |
| 2 |
Renaissance Technologies
New York
|
-$48K |
| 3 |
Morgan Stanley
New York
|
-$39.6K |
| 4 |
Squarepoint
New York
|
-$29K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$25K |
VANI Hedge Fund Activity: Q1 2021 in Review
30 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2021, worth a combined $27.3M — up 2,026% from $1.28M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VANI positions and 6 closed out — a net gain of 8 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $4.98M. The largest seller was Tower Research Capital (TRC), cutting an estimated $177K.
- 30 institutional investors held Vivani Medical (VANI) as of Q1 2021, up from 22 in Q4 2020.
- Funds reported $27.3M of Vivani Medical stock for Q1 2021, up 2,026% quarter-over-quarter.
- 14 funds opened new Vivani Medical positions in Q1 2021 and 6 closed out, a net change of +8 holders.
- The largest Vivani Medical buyer in Q1 2021 was Hudson Bay Capital Management, an estimated $4.98M added.
- The largest Vivani Medical seller in Q1 2021 was Tower Research Capital (TRC), an estimated $177K sold.
Based on aggregated 13F filings for Q1 2021.